Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus — Stella

Recruiting

Back to Central Diabetes Insipidus (cDI) trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Netherlands

Erasmus University Medical Center Rotterdam, Rotterdam

Switzerland

University Hospital Basel, Department of Endocrinology, Diabetes & Metabolism, Basel

Key details

Phase

Safety & dosing

Sponsor

University Hospital, Basel, Switzerland

Enrollment target

~112 participants

Started

January 2024

Primary completion

October 2026

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov